Tracy A. Lieu, MD, MPH

Articles by Tracy A. Lieu, MD, MPH

Breast Cancer Multigene Testing Trends and Impact on Chemotherapy Use

ByG. Thomas Ray, MBA,Jeanne Mandelblatt, MD,Laurel A. Habel, PhD,Scott Ramsey, MD, PhD,Lawrence H. Kushi, ScD,Yan Li, MD,Tracy A. Lieu, MD, MPH

May 17th 2016

A multigene test for breast cancer recurrence risk was used in a minority of eligible patients, yet was associated with a decrease in chemotherapy use.

Use of Well-Child Visits in High-Deductible Health Plans

ByAlison A. Galbraith, MD, MPH,Dennis Ross-Degnan, ScD,Stephen B. Soumerai, ScD,Allyson M. Abrams, MS,Kenneth Kleinman, ScD,Meredith B. Rosenthal, PhD,J. Frank Wharam, MB, BCh, BAO, MPH,Alyce S. Adams, PhD,Irina Miroshnik, MS,Tracy A. Lieu, MD, MPH

November 19th 2010

When preventive care was exempt from the deductible, well-child visits did not change for children switching from traditional plans to high-deductible plans.

Immunization Status Among Children Newly Enrolled in a Health Plan: A New Frontier for Quality Measurement?

ByTracy A. Lieu, MD, MPH,Mehran R. Massoudi, PhD, MPH,Irina L. Miroshnik, MS,Megan A. O'Brien, MPH,Kathryn L. Coltin, MPH,Lance E. Rodewald, MD, MP

February 1st 2003

Latest Updated Articles

Breast Cancer Multigene Testing Trends and Impact on Chemotherapy Use
Published: May 17th 2016 | Updated:
Immunization Status Among Children Newly Enrolled in a Health Plan: A New Frontier for Quality Measurement?
Published: February 1st 2003 | Updated:
Use of Well-Child Visits in High-Deductible Health Plans
Published: November 19th 2010 | Updated:

Tracy A. Lieu, MD, MPH

Articles by Tracy A. Lieu, MD, MPH

Breast Cancer Multigene Testing Trends and Impact on Chemotherapy Use

Use of Well-Child Visits in High-Deductible Health Plans

Immunization Status Among Children Newly Enrolled in a Health Plan: A New Frontier for Quality Measurement?

Latest Updated Articles

Trending on AJMC

Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure

KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials: Christof Vulsteke, MD, PhD

Adding Radioligand Therapy Pluvicto to SOC Cuts Risk of Prostate Cancer Progression or Death 28%, but How Many Doses?

FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes

3 New Study Findings to Look Out for at Menopause Society 2025